{
    "name": "Amundi LevDax Daily (2x) leveraged UCITS ETF Acc",
    "type": "ETF",
    "ucits": true,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage (2x)",
        "Synthetic replication via swaps",
        "Counterparty risk exposure",
        "Complex benchmark tracking (LevDAX)"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via an OTC swap contract to achieve its 2x leveraged exposure to the LevDAX index. This involves significant counterparty risk with institutions like Morgan Stanley and Societe Generale, as well as the inherent complexity of leveraged products. The KIID explicitly mentions risks associated with financial derivative instruments, including leverage risk and high volatility. The factsheet confirms the synthetic replication method and highlights counterparty risks. While UCITS-compliant, the combination of leverage and synthetic replication makes this a complex product under MiFID II.",
    "confidence": 95,
    "risk_level": 6,
    "counterparty_risk": true,
    "benchmark_complexity": true,
    "liquidity_risk": false,
    "capital_protection": false,
    "structured_features": false
}